Use App
  • Trending
  • News
  • Earnings
DIADIA0.94%
SPYSPY1.29%
QQQQQQ2.24%
Trending
Top trending tickerMUMU8.34%
SOXLSOXL13.98%
DXYZDXYZ2.00%
NTLANTLA3.39%
SPCXSPCX6.14%
MUUMUU16.70%
MARAMARA4.97%
MRAMMRAM6.31%
OSSOSS7.81%
LCIDLCID2.12%
Top trending tickerMUMU8.34%
SOXLSOXL13.98%
DXYZDXYZ2.00%
NTLANTLA3.39%
SPCXSPCX6.14%
MUUMUU16.70%
MARAMARA4.97%
MRAMMRAM6.31%
OSSOSS7.81%
LCIDLCID2.12%
homeSymbolLLY
LLY logo

LLYLilly(Eli) & Co

$1,129.98
$3.02
(0.27%)
Pre-Market
Updated: 04:45 AM EDT·Prev Close $1,133.00
EarningsAug 5
Mkt Cap$1.07T
Vol3,247.00

Fundamentals

Mkt Cap
$1.07T
Volume
-
52W High
$1,182.73
52W Low
$623.78
PE Ratio
40.78
Avg. Volume
3.32M
EPS (Annual)
$22.95
P/B
34.26
Rev/Employee
$1,303,580.00
Earnings
Aug 05

Feed

News

Sentiment

Earnings

Fundamentals

Info

Advertisement|Remove ads.

Latest LLY News

View
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Nasdaq News: Markets
News Placeholder
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
PR Newswire
News Placeholder
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
PR Newswire
News Placeholder
Loading...

Advertisement|Remove ads.

Advertisement|Remove ads.

TrendingNews
CommunityProfile